The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the lovenox that was provided to the patient.Since this event is associated with the treatment, this mdr will be against the instrument.A device service history review could not be performed as an instrument serial number was not provided.Trends were reviewed for complaint category, thrombosis.No trends were detected for this complaint category.The assessment is based on information available at the time of the investigation.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: thrombosis.(b)(4).
|
The customer reported that an extracorporeal photopheresis (ecp) patient experienced a deep vein thrombosis (dvt) following a treatment procedure.The customer stated that the patient had received their ecp treatments from (b)(6) 2019 to (b)(6) 2020 for chronic graft versus host disease.The customer reported that the patient was diagnosed with a right lower extremity dvt on (b)(6) 2019.The customer stated that the patient was being treated with lovenox, 80 mg, bid for their dvt.The customer reported that the patient continued with their ecp treatments after their dvt diagnosis with their last ecp treatment on (b)(6) 2020.No product was returned for investigation.
|